Supernus beats Allergan over epilepsy drug patents

(Reuters) - A federal judge on Friday said Allergan Plc's planned generic version of a drug meant to treat epilepsy infringed patents belonging to Supernus Pharmaceuticals Inc.

http://ift.tt/1Pc385f

from Reuters: Health News
via animenewspro